Iovance Biotherapeutics Announces Clinical Data for Lifileucel in Combination with Pembrolizumab in Advanced Cancers at Society for Immunotherapy of Cancer (SITC) Annual Meeting

NEXT STORY
Lexicon’s Sotagliflozin Demonstrates Benefits in Heart Failure and Blood Glucose Control Across the Full Range of Kidney Function in New Analysis of Clinical Data
PREV STORY
Positive Phase-IIb-Ergebnisse bei Zweitlinienbehandlung von Melanomen
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Trogarzo® Phase III Data Analysis Presented at HIV Drug Therapy Glasgow 2018: Patients not achieving primary endpoint at day 7 experienced clinical benefit by end of study

MONTREAL, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced that ...

author_avatar
NASDAQ Market News

Survey Shows Divergent Trends in Provider Compensation and Productivity

author_avatar
NASDAQ Market News

BeyondSpring’s Novel Study 103 Phase 3 Design in NSCLC Presented at 2019 IASLC World Conference on Lung Cancer

author_avatar
NASDAQ Market News